tiprankstipranks
pc:med72

Mediar Therapeutics

Mediar Therapeutics is a clinical-stage biotechnology company developing first-in-class therapies designed to halt fibrosis by targeting the myofibroblast, the key pathogenic cell driving scarring and organ failure. The company advances antibody therapeutics across multiple organ systems with programs in systemic sclerosis, idiopathic pulmonary fibrosis, and chronic kidney disease.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$76M
Total Amount Raised$76M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$76M
Latest Funding Amount$76M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 07, 2026
Series B
$76.00M

Investors

Related News and Analysis